Stocks and Investing Stocks and Investing
Tue, October 13, 2020

Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $273 on, Oct 13th, 2020


Published on 2024-10-27 14:20:08 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $281 to $273 on, Oct 13th, 2020.

Matthew has made no other calls on AMGN in the last 4 months.



There are 10 other peers that have a rating on AMGN. Out of the 10 peers that are also analyzing AMGN, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Robyn Karnauskas of "Truist Securities" Downgraded from Strong Buy to Hold and Decreased Target to $251 on, Monday, October 12th, 2020
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, October 9th, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Increased Target to $261 on, Wednesday, July 29th, 2020
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $250 on, Wednesday, July 29th, 2020
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $232 on, Wednesday, July 29th, 2020


These are the ratings of the 5 analyists that currently disagree with Matthew


  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $280 on, Tuesday, October 6th, 2020
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Increased Target to $300 on, Wednesday, July 29th, 2020
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $279 on, Wednesday, July 29th, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $270 on, Wednesday, July 29th, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $290 on, Monday, July 20th, 2020
Contributing Sources